XML 142 R124.htm IDEA: XBRL DOCUMENT v3.5.0.1
Stock Incentive Plans - Schedule of Options (Details) - Stock Options - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Apr. 01, 2016
Apr. 03, 2015
Mar. 28, 2014
Mar. 29, 2013
Number of Option Shares        
Outstanding beginning of period (in shares) 5,556,309 9,829,611 15,140,567  
Granted (in shares) 1,052,129 1,331,862 2,199,369  
Issued due to Separation modification (in shares) 1,614,465      
Exercised (in shares) (2,372,109) (4,476,715) (5,015,849)  
Canceled/Forfeited (in shares) (434,578) (1,057,332) (1,247,511)  
Expired (in shares) (49,595) (71,117) (1,246,965)  
Outstanding end of period (in shares) 5,366,621 5,556,309 9,829,611 15,140,567
Weighted Average Exercise Price        
Weighted average exercise price -beginning of period (in dollars per share) $ 46.08 $ 43.30 $ 43.23  
Weighted average exercise price - granted (in dollars per share) 30.70 60.89 45.20  
Weighted average exercise price - issued due to Separation modification (in dollars per share) 28.40      
Weighted average exercise price - exercised (in dollars per share) 19.27 45.19 44.10  
Weighted average exercise price - cancelled/forfeited (in dollars per share) 28.59 42.67 33.89  
Weighted average exercise price - expired (in dollars per share) 20.87 45.53 52.05  
Weighted average exercise price - end of period (in dollars per share) $ 24.83 $ 46.08 $ 43.30 $ 43.23
Additional Disclosures        
Weighted average remaining contractual life (in years) 7 years 22 days 5 years 11 months 5 days 5 years 8 months 23 days 5 years 5 months 12 days
Aggregate intrinsic value $ 51 $ 107 $ 167 $ 113
Total intrinsic value of options exercised during the period $ 46 $ 82 $ 53  
Vested and Expected to Vest        
Vested and expected to vest in the future as of period end (in shares) 5,185,363      
Exercisable as of period end (in shares) 3,070,934      
Weighted average exercise price vested and expected to vest as of period end (in dollars per share) $ 24.63      
Weighted average exercise price exercisable as of period end (in dollars per share) $ 20.79      
Weighted average remaining contractual life vested and expected to vest in the future as of period end (in years) 6 years 11 months 23 days      
Weighted average remaining contractual life exercisable as of period end (in years) 5 years 7 months 2 days      
Aggregate intrinsic value vested and expected to vest in the future as of period end $ 50      
Aggregate intrinsic value exercisable as of period end $ 41